Reports for SANDOZ IRBESARTAN HCT
Brand name
SANDOZ IRBESARTAN HCT
Company Name
SANDOZ CANADA INCORPORATED
|
Drug Identification Number
02337436 |
Ingredients
HYDROCHLOROTHIAZIDE IRBESARTAN |
Ingredient Strength
12.5 MG 300 MG |
ATC Code
C09DAC09DA |
ATC Descriptor
ANGIOTENSIN II ANTAGONISTS, COMBINATIONS ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
Status
MARKETED
|
Shortage reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|
| SANDOZ IRBESARTAN HCT | 100 | Resolved | 2019-03-05 | 2020-07-20 | 77655 |
| SANDOZ IRBESARTAN HCT | 500 | Resolved | 2019-04-01 | 2020-06-22 | 80194 |
| SANDOZ IRBESARTAN HCT | 100FCT BO CA | Resolved | 2020-09-21 | 2020-10-27 | 124609 |
| SANDOZ IRBESARTAN HCT | 500FCT BO CA | Resolved | 2020-09-21 | 2020-10-27 | 124612 |
| SANDOZ IRBESARTAN HCT | 100FCT | Resolved | 2023-03-06 | 2023-03-28 | 186285 |
| SANDOZ IRBESARTAN HCT | 100FCT BO | Resolved | 2023-08-07 | 2023-08-15 | 201264 |
| SANDOZ IRBESARTAN HCT | 500FCT | Resolved | 2023-12-04 | 2024-01-18 | 212445 |
Showing 1 to 7 of 7
Discontinuation reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|
Showing 1 to 0 of 0